Track the Oxford Biomedica plc stock price and the full management transaction log of the company, a listed equity based in United Kingdom. Shares are quoted on UK GB, under the oversight of RNS (LSE). Market capitalisation: €760.1m. The latest transaction was reported on 25 May 2026 (sold). Among the most active insiders: Natalie Walter. All data is accessible without an account.
8
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€652,452
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Oxford Biomedica plc Strong Buy (bullish), based on 8 analysts. Average price target: £842.38.
15Σ signal
Buys ·€652,452 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 22,269 of 26,176 companies
26.5
score / 100
Value
29
Quality
24
FCF yld-0.6%
Earn yld-4.1%
EV/EBITDA·
ROE-40%
Gross mgn39%
Net mgn-18%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0100.0% of flowLondon Stock Exchange (XLON)RNS:5700121
8 of 8 declarations
About Oxford Biomedica plc
Oxford Biomedica plc is a UK-based biopharmaceutical company specializing in the development of gene and cell therapies. It focuses on the manufacturing of viral vectors for innovative treatments.